Literature DB >> 15132252

Animal models of hypoxic-ischemic brain damage in the newborn.

Jerome Y Yager1.   

Abstract

Controversy continues over which animal model to use as a reflection of human disease states. With respect to perinatal brain disorders, scientists must contend with a disease in evolution. In that regard, the perinatal brain is at risk during a time of extremely rapid development and maturation, involving processes that are required for normal growth. Interfering with these processes, as part of therapeutic intervention must be efficacious and safe. To date, numerous models have provided tremendous information regarding the pathophysiology of brain damage to term and preterm infants. Our challenges will continue to be in identifying those infants at greatest risk for permanent injury, and adapting therapies that provide more benefit than harm. Using animal models to conduct these studies will bring us closer to that goal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15132252     DOI: 10.1016/j.spen.2004.01.006

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  16 in total

1.  Tert-butylhydroquinone post-treatment attenuates neonatal hypoxic-ischemic brain damage in rats.

Authors:  Juan Zhang; Lorelei Donovan Tucker; Yujiao Lu; Luodan Yang; Chongyun Wu; Yong Li; Quanguang Zhang
Journal:  Neurochem Int       Date:  2018-03-09       Impact factor: 3.921

2.  Neurobehavioral Assessments in a Mouse Model of Neonatal Hypoxic-ischemic Brain Injury.

Authors:  MinGi Kim; Ji Hea Yu; Jung Hwa Seo; Yoon-Kyum Shin; Soohyun Wi; Ahreum Baek; Suk-Young Song; Sung-Rae Cho
Journal:  J Vis Exp       Date:  2017-11-24       Impact factor: 1.355

3.  The cannabinoid WIN 55212-2 mitigates apoptosis and mitochondrial dysfunction after hypoxia ischemia.

Authors:  D Alonso-Alconada; A Alvarez; F J Alvarez; J A Martínez-Orgado; E Hilario
Journal:  Neurochem Res       Date:  2011-09-11       Impact factor: 3.996

4.  Hypothermia for hypoxic ischemic encephalopathy in infants > or =36 weeks.

Authors:  Rosemary D Higgins; Seetha Shankaran
Journal:  Early Hum Dev       Date:  2009-09-17       Impact factor: 2.079

Review 5.  New concepts in perinatal hypoxia ischemia encephalopathy.

Authors:  Joseph Scafidi; Vittorio Gallo
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

6.  Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop.

Authors:  Rosemary D Higgins; Tonse Raju; A David Edwards; Denis V Azzopardi; Carl L Bose; Reese H Clark; Donna M Ferriero; Ronnie Guillet; Alistair J Gunn; Henrik Hagberg; Deborah Hirtz; Terrie E Inder; Susan E Jacobs; Dorothea Jenkins; Sandra Juul; Abbot R Laptook; Jerold F Lucey; Mervyn Maze; Charles Palmer; Luann Papile; Robert H Pfister; Nicola J Robertson; Mary Rutherford; Seetha Shankaran; Faye S Silverstein; Roger F Soll; Marianne Thoresen; William F Walsh
Journal:  J Pediatr       Date:  2011-08-27       Impact factor: 4.406

Review 7.  Neurological outcomes of animal models of uterine artery ligation and relevance to human intrauterine growth restriction: a systematic review.

Authors:  Alfred Basilious; Jerome Yager; Michael G Fehlings
Journal:  Dev Med Child Neurol       Date:  2014-10-21       Impact factor: 5.449

8.  Fibroblast growth factor-2 induced by enriched environment enhances angiogenesis and motor function in chronic hypoxic-ischemic brain injury.

Authors:  Jung Hwa Seo; Ji Hea Yu; Hwal Suh; Myung-Sun Kim; Sung-Rae Cho
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

9.  Role of immunoglobulin in neuronal apoptosis in a neonatal rat model of hypoxic ischemic brain injury.

Authors:  Salih Kalay; Osman Oztekin; Gönül Tezel; Hakan Aldemir; Emel Sahin; Sadi Köksoy; Mustafa Akçakuş; Nihal Oygur
Journal:  Exp Ther Med       Date:  2014-01-02       Impact factor: 2.447

10.  Neuroprotective therapies after perinatal hypoxic-ischemic brain injury.

Authors:  Felipe Goñi de Cerio; Idoia Lara-Celador; Antonia Alvarez; Enrique Hilario
Journal:  Brain Sci       Date:  2013-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.